Rapidly Ageing Population in Europe Boosts Prospects of Assisted Living Technologies Markets

An increasing ageing population and the associated need for healthcare services have heightened government attention on assisted living technologies, promoting the growth of this market in Europe. Early stages of technological and market development and limited awareness about the advantages of assisted living technologies threaten growth prospects. However, product customisation will help mitigate these challenges.

New analysis from Frost & Sullivan, European Markets for Assisted Living Technologies, finds that the markets earned revenues of $154.92 million in 2009 and estimates this to reach $525.58 million in 2015. The research closely examines assisted living devices for use in residences and institutions.

"A rapidly expanding elderly population in Europe is driving the need for continuous care, with mitigating this challenge featuring high on the agenda of governments in several European countries," notes Frost & Sullivan Research Analyst Somsainathan. "Governments are keen to address the needs of the elderly and provide the right social care to reduce the healthcare costs involved. Such trends are spurring the development of the market for assisted living technologies."

Rising awareness, coupled with the burgeoning need for assisted living technologies, are motivating market advancement. Participants are keen on capitalising on the end-user acceptance of these technologies and augmenting their shares in a market that is becoming increasingly competitive.

The market is developing at a brisk pace, surpassing the general healthcare industry average, mainly due to the spiralling demand for assisted living technologies. The increasing recognition of assisted living technologies is allowing participants to penetrate into the market with ease. Competition is intensifying rapidly, encouraging market participants to expand their geographic scope and improve their product portfolio.

However, high initial costs and shrinking budgets are the most important challenges for market participants. Similarly, the privacy and confidentiality issues involved have made end users reluctant to adopt such solutions.

"The high initial costs involved in setting up assisted living services have been paralleled by the post-recession phase which has led to shrinking healthcare budgets," explains Somsainathan. "Moreover, confidentiality and privacy issues in terms of data collected about end users have made many end users wary about adopting such technologies."

Product customisation and developing user-friendly technologies are key to boosting market penetration. A proper understanding of client needs will help design the right solutions, especially when the target client pool are the elderly who, in general, are sceptical of technological devices.

"Developing technologies that are user-friendly and marketable to the elderly population is critical to maintaining growth momentum," concludes Somsainathan. "Understanding client needs and ensuring product customisation based on this information will ensure success for assisted living technologies."

If you are interested in more information on Frost & Sullivan's latest study on European Markets for Assisted Living Technologies, please send an e-mail to Katja Feick, Corporate Communications, at This email address is being protected from spambots. You need JavaScript enabled to view it., with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

European Markets for Assisted Living Technologies is part of the Patient Monitoring Growth Partnership Services programme, which also includes research in the following markets: Data Management Systems for Patient Monitoring Markets in Europe, European Market for non- Invasive Blood Pressure Monitors, European Telemetry Equipment Market and European Pulse Oximetry Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Most Popular Now

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...